Welcome to our dedicated page for C3.Ai SEC filings (Ticker: AI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The C3.ai, Inc. (NYSE: AI) SEC filings page provides access to the company’s official disclosures as an Exchange Act registrant. C3 AI, described as an Enterprise AI application software company, files annual reports, quarterly updates, current reports, proxy statements, and registration documents with the U.S. Securities and Exchange Commission. These filings give detailed insight into its enterprise AI business, capital structure, governance, and risk factors.
Through its Form 10-K annual report and Form 10-Q quarterly reports, C3 AI presents audited and interim financial statements, segment information for subscription and professional services revenue, and discussions of its products such as the C3 Agentic AI Platform, C3 AI applications, and C3 Generative AI. Management also explains the use of non-GAAP metrics like non-GAAP gross profit, non-GAAP loss from operations, and free cash flow, alongside reconciliations to GAAP measures.
Form 8-K current reports document material events, including quarterly earnings releases, changes in executive leadership, adoption of equity incentive plans, director appointments, and outcomes of the annual meeting of stockholders. For example, recent 8-K filings describe the appointment of a new Chief Executive Officer, the establishment of a 2025 Inducement Plan for equity awards, and the election of directors and ratification of the independent auditor.
The company’s proxy statements (DEF 14A) provide detail on board composition, executive compensation, equity plans, and voting procedures for stockholders. Additional registration statements and plan-related filings describe the terms of equity compensation arrangements, including inducement awards under NYSE rules.
On Stock Titan, these C3 AI filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly identify items such as revenue composition, major contracts or business themes discussed in management’s commentary, and governance or compensation changes disclosed in proxy materials. Real-time updates from EDGAR ensure that new C3 AI filings, including future 10-K, 10-Q, 8-K, and proxy statements, are added as they become available.
Condoleezza Rice, a director of C3.ai, Inc. (AI), reported transactions on 10/03/2025 affecting both Class A common stock and stock options. The filing shows a sale of 312 Class A shares at $1.86, leaving 74,699 Class A shares beneficially owned directly after the sale. An additional 587 shares are held indirectly in a trust where she is trustee.
The report also discloses two option transactions dated 10/03/2025: a fully vested option for 312 shares (exercise price $1.86) and an acquisition of an option for 28,628 shares at an exercise price of $19.16 that vests quarterly over up to two years conditioned on in-person board meeting attendance, with a final exercisability/expiration schedule extending to 10/02/2035.
C3.ai filed a Form 4 reporting a director stock option for 32,309 shares of Class A common stock at an exercise price of $19.16, granted on October 3, 2025. The option expires on October 2, 2035.
Vesting begins October 3, 2025: 12.5% of the option vests on the last day of each fiscal quarter in which the director attends the regularly scheduled board meeting in person over two years. Any quarter missed suspends that tranche; suspended tranches vest only after the second anniversary if subsequent attendance requirements are met.
Director Jim H. Snabe received a stock option award for 28,628 shares of Class A common stock with an exercise price of $19.16. The option was granted on 10/03/2025 and has an expiration/exercise term tied to an expiration date of 10/02/2035. The award vests in 12.5% increments on the last day of each regularly scheduled quarterly board meeting starting on the vesting commencement date of 10/03/2025, subject to in-person attendance; any quarterly vesting missed will be suspended and may vest only after the second anniversary if attendance requirements are later met. The Form 4 was filed as a report by one reporting person and signed by an attorney-in-fact on 10/07/2025.
C3.ai, Inc. director John E. Hyten was granted $0-priced stock option rights to buy 28,628 shares of Class A common stock on 10/03/2025. The option has an exercise price of $19.16 and an expiration/exercisability reference of 10/02/2035. Vesting begins on the Vesting Commencement Date of 10/03/2025 with 12.5% of the option shares vesting on the last day of each fiscal quarter for up to two years, provided the reporting person attends the regularly scheduled board meeting each quarter. Missed meetings suspend vesting for the affected quarterly tranche, which may only vest later if attendance requirements are met after the suspension.
Insider equity grant to a director with attendance‑based vesting. A Form 4 shows Director Richard C. Levin received a stock option to purchase 28,628 shares of Class A common stock exercisable at $19.16. The option grant date is 10/03/2025 with an expiration on 10/02/2035 and the option appears fully reported as a direct holding of 28,628 shares after the acquisition. Vesting begins on the Vesting Commencement Date (10/03/2025) and 12.5% of the shares vest on the last day of each fiscal quarter only if the director attends the regularly scheduled board meeting for that quarter; missed meetings suspend quarterly vesting and those suspended shares vest only if attendance requirements are later satisfied after the two‑year anniversary.
C3.ai director and EVP & Chief Commercial Officer Robert David Schilling received 470,420 fully vested Restricted Stock Units (RSUs) that convert one-for-one into Class A common shares. To cover tax withholding on those vested RSUs, the issuer automatically withheld and sold 240,121 shares at a weighted-average price of $17.2899. Separately, 230,299 shares were sold under a previously established Rule 10b5-1 trading plan dated June 23, 2025, also reported at a weighted-average price of $17.2899. Following the reported transactions, the filing shows beneficial ownership levels of 1,481,747, 1,241,626, and 1,011,327 shares on the separate reported lines respectively.
C3.ai, Inc. (AI) filed a Form 144/A notifying a proposed sale of 470,420 shares of common stock to be executed on or about 10/01/2025 on the NYSE through Merrill Lynch, 520 Newport Center Drive, Newport Beach, CA. The filing lists an aggregate market value of $8,133,514.76 for the shares and indicates 134,349,704 shares outstanding. The securities were acquired on 10/01/2025 as a stock bonus from C3 AI Inc., with payment and acquisition dates shown as the same date. No sales by the reporting person in the prior three months are reported. The filer affirms they are unaware of any undisclosed material adverse information about the issuer.
C3.ai, Inc. (AI) filed a Form 144 giving notice of a proposed sale of 470,420 shares of common stock through Merrill Lynch at an aggregate market value of $8,133,514.76. The filing shows 134,349,704 shares outstanding and lists the approximate date of sale as 10/01/2025. The securities were acquired as a stock bonus from C3 AI Inc. on 10/01/2025, with payment and consideration marked as N/A. The filer certifies they are unaware of undisclosed material adverse information about the issuer as part of the Form 144 signature representations.
C3.ai, Inc. announced that on September 14, 2025 its Board unanimously adopted the C3.ai, Inc. 2025 Inducement Plan, authorizing equity-based inducement awards to recruit and retain new employees. The plan reserves 5,000,000 shares of Class A common stock for non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants under the plan are limited to new hires who meet NYSE "employment inducement" standards and require approval by independent directors or a wholly independent Compensation Committee. The plan was adopted without stockholder approval pursuant to NYSE rules and is incorporated by reference to the Form S-8 Exhibit 99.1.
Stephen Bradley Ehikian, Chief Executive Officer of C3.ai (AI), received equity awards on 09/15/2025 consisting of 1,140,902 RSUs and a stock option for 1,282,139 shares with a $17.53 exercise price. The RSUs convert to one share each on settlement; 399,316 RSUs vest on December 30, 2025 and the remainder vest in 11 equal quarterly installments thereafter provided continued service. The option vests 5% on December 15, 2025 and 5% quarterly thereafter and expires on September 14, 2035. The reported beneficial ownership figures after the transactions are 1,140,902 shares for RSUs and 1,282,139 underlying shares for the option. The Form 4 was signed by an attorney-in-fact on 09/17/2025.